Israeli company NLT Spine, a developer of products for minimally invasive spine surgery and percutaneous procedures, has named Peter Wehrly to its board of directors. With 25 years in the medical device industry, he brings heavyweight experience including having served as president of Medtronic Inc.’s Spinal, Biologics and Navigation Division.
“As we prepare the platform’s introduction in the market, we are happy to have Peter Wehrly on our Board of Directors,” said Didier Toubia, NLT Spine’s CEO. “As a seasoned executive Peter can contribute from his vast knowledge, experience and network to advance our commercialization strategy. I am positive that his contribution will be invaluable to NLT Spine.”
Wehrly is the group president of Covidien plc, a position he has held since July 2011. In this capacity, he is responsible for the respiratory & monitoring solutions and vascular therapy businesses, as well as the Japan, Australia-New Zealand, and Canada businesses. Wehrly has also held several executive-level roles at Medingo, a company that produces insulin patches, and Medtronic. He is a graduate of Ball State University in Muncie, Ind., with a bachelor of science degree in Management.
“Joining as a board member at NLT Spine will enable me to work closely with a team of experts in their fields to advance the company’s impressive technology platform, which addresses important surgical problems,” Wehrly commented. “The ingenuity and industrious nature of the development team, characteristic of Israeli life science start-up companies, played a major part in my decision to take part in bringing this technology to the market.”